PGC-1alpha Gly482Ser polymorphism is associated with the plasma adiponectin level in type 2 diabetic men.
暂无分享,去创建一个
M. Matsuda | T. Funahashi | I. Shimomura | Y. Horikawa | K. Yamagata | J. Miyagawa | Toshiya Tanaka | H. Iwahashi | K. Okita | M. Yuan | Yukiyoshi Okauchi
[1] Y. Pak,et al. Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) on mitochondrial transcription factor A (Tfam) promoter , 2006 .
[2] M. Ridderstråle,et al. Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men , 2006, Diabetologia.
[3] S. O’Rahilly,et al. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes , 2006, Diabetologia.
[4] T. Hansen,et al. PGC-1α Gly482Ser Polymorphism Associates With Hypertension Among Danish Whites , 2005 .
[5] C. Bellanné-Chantelot,et al. The Gly482Ser polymorphism in the peroxisome proliferator-activated receptor-γ coactivator-1 gene is associated with hypertension in type 2 diabetic men , 2004, Diabetologia.
[6] E. Carlsson,et al. Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins. , 2004, The Journal of clinical investigation.
[7] Nader Rifai,et al. Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.
[8] M. Matsuda,et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. , 2003, Diabetes.
[9] O. Pedersen,et al. A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. , 2003, Diabetes.
[10] U. Smith,et al. Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance. , 2003, Biochemical and biophysical research communications.
[11] B. Paulweber,et al. Peroxisome Proliferator–Activated Receptor-&ggr; Coactivator-1 Gene Locus: Associations with Hypertension in Middle-Aged Men , 2003 .
[12] Helen Santini. Rebirth of the health-care system in Cambodia , 2002, The Lancet.
[13] R. A. Norman,et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. , 2002, Diabetes.
[14] M. Matsuda,et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. , 2002, Diabetes.
[15] Jonathan Krakoff,et al. Adiponectin and development of type 2 diabetes in the Pima Indian population , 2002, The Lancet.
[16] M. Matsuda,et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.
[17] T. Kadowaki,et al. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes , 2002, Diabetologia.
[18] B. Paulweber,et al. Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Gene Locus Associations With Obesity Indices in Middle-Aged Women , 2002 .
[19] T. Hansen,et al. Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus , 2001, Diabetologia.
[20] Y. Terauchi,et al. The Mechanisms by Which Both Heterozygous Peroxisome Proliferator-activated Receptor γ (PPARγ) Deficiency and PPARγ Agonist Improve Insulin Resistance* , 2001, The Journal of Biological Chemistry.
[21] Guillaume Adelmant,et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.
[22] M. Matsuda,et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.
[23] Y. Terauchi,et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.
[24] T. Funahashi,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .
[25] T Nakamura,et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.
[26] NoriyukiOuchi,et al. Novel Modulator for Endothelial Adhesion Molecules , 1999 .
[27] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[28] J. Miyazaki,et al. Mutation P291fsinsC in the Transcription Factor Hepatocyte Nuclear Factor-1α is Dominant Negative , 1998, Diabetes.
[29] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[30] M. Dieudonné,et al. Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. , 1998, American journal of physiology. Cell physiology.
[31] P. Puigserver,et al. A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.
[32] Y. Pak,et al. Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter. , 2006, Biochemical and biophysical research communications.
[33] S. Soyal,et al. PGC-1α: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes , 2006, Diabetologia.
[34] S. O’Rahilly,et al. Expression of the thermogenic nuclear hormone receptor coactivator PGC-1α is reduced in the adipose tissue of morbidly obese subjects , 2004, International Journal of Obesity.
[35] T. Funahashi,et al. Decreased plasma adiponectin concentration in patients with essential hypertension. , 2003, American journal of hypertension.
[36] P. Boutin,et al. No association between the G482S polymorphism of the proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene and Type II diabetes in French Caucasians. , 2002, Diabetologia.
[37] J. Auwerx,et al. The generation of monoclonal antibodies against human peroxisome proliferator-activated receptors (PPARs). , 2002, Journal of atherosclerosis and thrombosis.
[38] Y. Terauchi,et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. , 2001, The Journal of biological chemistry.